Veteran tech investor joins China’s state-owned CICC Capital

The following year, he oversaw the firm’s backing of US biotech group Ambrx, alongside consortium members Shanghai Fosun Pharmaceutical, China Everbright and Wuxi Pharmatech. Mr Li headed the launch t...

Read the original article: shanghai china - BingNews